MiR-29a/DNMT3A axis participates in Dihydroartemisinin's suppression on lung adenocarcinoma: Implications for overcoming acquired resistance to EGFR-TKIs
{{output}}
Dihydroartemisinin (DHA), the traditional antimalarial agent, has attracted significant interest as potential anticancer drug, yet its underlying mechanisms are incompletely understood. Herein, we showed that DNA methyltransferase 3 alpha (DNMT3A), a de novo D... ...
